TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.46, ss.100-104, 2021 (SCI-Expanded)
BACKGROUND AND AIM: This study aimed to determine tunicamycin
(TM)-related sphingolipid and polyunsaturated fatty acid (PUFA) changes
in human kidney cells (HEK-293) and their effects on inflammatory and
apoptotic pathways. Tunicamycin was employed to induce endoplasmic
reticulum (ER) stress in HEK-293 cells and an ER stress inhibitor,
tauroursodeoxycholic acid (TUDCA), was given to minimize cytotoxicity.
METHODS: Cell viability was determined by MTT assay. Sphingomyelin (SM),
ceramide (CER) and PUFA levels were measured by liquid chromatography-tandem
mass spectrometry (LC-MS/MS). Glucose-regulated protein 78-kd (GRP78),
cleaved caspase-3 and cyclooxygenase-1 (COX-1) protein levels were assessed
by immunofluorescence. Cytosolic phospholipase A2 (cPLA2), total COX and
prostaglandin E2 (PGE2) were measured to evaluate changes in enzyme activity.
RESULTS: Decreased cell viability was observed in TM treated cells.
Administration of TUDCA following TM treatment significantly increased cell
viability compared to TM treatment alone. Tunicamycin-induced ER stress was
confirmed by significantly increased protein levels of GRP78. A significant
increase was observed in C18-C24 CERs and caspase-3 activity, while a
significant decrease occurred in sphingosine-1-phosphate (S1P) and cPLA2
activity in cells treated with μg/ml versus controls. The decrease in cPLA2
activity was accompanied by significantly increased PUFA levels in TM treated
cells. Tauroursodeoxycholic acid treatment in conjunction with TM significantly
decreased ER stress, C18-C24 CERs, caspase 3 activity and increased S1P levels.
CONCLUSIONS: Results show the build-up of long chain CERs and PUFAs
in HEK-293 cells undergoing ER stress alongside increased apoptotic activity.
Tauroursodeoxycholic acid administration, along with TM treatment alleviated
the build-up of CERs and TM-induced apoptotic activity in kidney epithelial cells.
Keywords: Ceramide, Kidney, PUFA, Sphingolipid, Tunicamycin